Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Reaction Biology Corporation has received a subcontract from Leidos Biomedical Research, which operates the Frederick National Laboratory for Cancer Research for the National Cancer Institute.
read more
Phoenix Molecular Designs (PhoenixMD) has announced the completion of clinical trial supply manufacture for PMD-026.
read more
Cambrex has completed a new 600 m2 facility at its site in Karlskoga, Sweden, which incorporates new laboratories for process and analytical development.
read more
PCI has announced the growth of its West Coast Clinical operations with expansion into its third facility in San Diego.
read more
Sterling Pharma Solutions has announced the expansion of its pilot plant facility is now operational at its UK site following a £6million investment last year.
read more
Almac Sciences announced the appointment of Dr. Sheryl Foster to the position of Vice President of Quality, reporting to Managing Director & President, Dr. Stephen Barr.
read more
Quanterix announced the relocation of its headquarters to a brand new facility in Billerica, Mass.
read more
Thermo Fisher Scientific has announced a collaboration with Scinogy to develop and commercialize fit-for-purpose instrumentation and reagent systems.
read more
Aldevron has announced expansion plans for a 14-acre campus at its headquarters in Fargo, N.D.
read more
HitGen has entered into a drug discovery research collaboration with Gilead Sciences to identify potential small molecule leads against targets of interest to Gilead.
read more
Devonian and Histapharm announced they have signed a binding LOI to negotiate the terms establishing Devonian as the exclusive site for manufacturing of Histapharm’s proprietary botanical drug.
read more
Beam Therapeutics and Bio Palette today announced an exclusive cross-license agreement around each companies’ base editing intellectual property.
read more
Evidera has entered into an agreement to acquire Medimix International, a technology company providing RWE insights and information to the pharmaceutical, diagnostic and medical device industries.
read more
Iovance Biotherapeutics has expanded its relationship with WuXi AppTec's Advanced Therapies Business Unit (WuXi ATU).
read more
Lantheus Holdings has entered into an agreement with NanoMab Technology, a biopharmaceutical company focusing on the development of next generation radiopharmaceuticals to be used in the development of immuno-oncology therapies.
read more